25 Apr, EOD - Indian

SENSEX 79212.53 (-0.74)

Nifty 50 24039.35 (-0.86)

Nifty Bank 54664.05 (-0.97)

Nifty IT 35562.25 (0.72)

Nifty Midcap 100 53570.2 (-2.55)

Nifty Next 50 64314.9 (-2.41)

Nifty Pharma 21482.55 (-2.24)

Nifty Smallcap 100 16547.2 (-2.45)

25 Apr, EOD - Global

NIKKEI 225 35705.74 (1.90)

HANG SENG 21980.74 (0.32)

S&P 5564.5 (0.75)

LOGIN HERE

companylogoChemcrux Enterprises Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 540395 | NSE Symbol : | ISIN : INE298W01016 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
04-Feb-2025 11-Feb-2025 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve 1. Unaudited Financial Results for the third quarter and nine months ended 31st December 2024 of FY 2024-25 and other related matters thereto. 2. To consider any other business /agenda. Unaudited Financial Results for the third quarter and nine months ended 31st December 2024 for FY 2024-25 as reviewed and recommended by the Audit Committee along with Limited Review Report issued by Statutory Auditors of the Company, Naresh & Co., Chartered Accountants. (As Per BSE Announcement Dated on 11/02/2025)
29-Oct-2024 11-Nov-2024 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve 1. Unaudited Financial Results for the quarter and half year ended 30th September 2024 for FY 2024-25 and other related matters thereto. 2. To consider any other business /agenda. Unaudited Financial Results for the quarter and half year ended 30th September 2024 (As Per BSE Announcement Dated on: 11/11/2024)
23-Jul-2024 30-Jul-2024 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2024 inter alia to consider and approve 1. Unaudited Financial Results for the quarter ended on 30th June 2024 for FY 2024-25 and other related matters thereto. 2. Any other business /agenda. The Board of Directors of the Company at their meeting held today i.e., Tuesday, 30th July 2024 at the Registered Office of the Company at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia: 1. Considered and approved the Unaudited Standalone & Consolidated Financial Results for the quarter ended 30th June 2024 for FY 2024-25 along with Limited Review Report thereon as reviewed and recommended by the Audit Committee. 2. The 28th Annual General meeting of the company shall be held on Friday, 13th September 2024 at 02:00 PM through Video Conferencing. Appointment of Secretarial Auditor (As Per BSE Announcement dated on 30.07.2024)
29-Apr-2024 06-May-2024 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2024 inter alia to consider and approve 1. Audited Financial Statements and Results for the 4th quarter and year ended 31st March 2024 for the FY 2023-24 and other related matters thereto. 2. Recommendation of Final Dividend if any for the F.Y. 2023-24 subject to approval of the same by the members in the ensuing Annual General Meeting. 3. Any other business /agenda. Recommendation of Dividend @ 10% (Re. 1/-) per share subject to shareholders approval at the ensuing AGM for the FY 2023-24 Board of Directors re-appointed M/s. KR & Associates as Internal Auditors for conducting Internal Audit from FY 2024-25 onwards. (As Per BSE Announcement Dated on 06/05/2024)
06-Feb-2024 13-Feb-2024 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Unaudited Standalone Financial Results for the third quarter and nine months ended 31st December 2023 of FY 2023-24 and other related matters thereto. The Board of Directors of the Company at their meeting held today i.e., Tuesday, 13th February 2024 at the Registered Office of the Company located at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia: 1. Considered and approved the Unaudited Standalone Financial Results for the 3rd quarter and nine months ended 31st December 2023 of the FY 2023-24 as reviewed and recommended by the Audit Committee along with Limited Review Report issued by Statutory Auditors of the Company, Naresh & Co., Chartered Accountants. 2. Pursuant to Regulation 30 of the SEBI (Listing Regulations and Disclosure Requirements) Regulations, 2015 as amended, Board approved and adopted the revised Policy for Determination of Materiality of Events or Information. The revised policy is being uploaded on the website of the Company at www.chemcrux.com. (As Per BSE Announcement Dated on: 13/02/2024)
08-Dec-2023 08-Dec-2023 Change in Other Executives The Board of Directors of the Company at their meeting held today i.e., on 08th December 2023; have appointed Mr. Ramesh Kambariya as Chief Financial Officer (KMP) of the Company w.e.f. 08th December 2023.
03-Nov-2023 09-Nov-2023 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Unaudited Standalone Financial Results for the 2nd quarter and half year ended 30th September 2023 of FY 2023-24 and other related matters thereto. The Board of Directors of the Company at their meeting held today i.e., Thursday, 09th November 2023 at the Registered Office of the Company located at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia: Considered and approved the Unaudited Standalone Financial Results for the 2nd quarter and Half Year ended 30th September 2023 of the FY 2023-24 as reviewed and recommended by the Audit Committee along with Limited Review Report issued by Statutory Auditors of the Company, Naresh & Co., Chartered Accountants. (As per BSE Announcement Dated on 09/11/2023)
28-Jul-2023 04-Aug-2023 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 inter alia to consider and approve Unaudited Standalone Financial Results for the 1st quarter ended on 30th June 2023 of FY 2023-24 and other related matters thereto. The Board of Directors of the Company at their meeting held on Friday, 04th August 2023 at the Registered Office of the Company at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia: 1. Considered and approved the Unaudited Standalone Financial Results for the 1st quarter ended 30th June 2023 of the FY 2023-24 along with Limited Review Report thereon as reviewed and recommended by the Audit Committee. 2. The 27th Annual General meeting of the company shall be held on Tuesday, 12th September 2023 at 02:00 PM through Video Conferencing. Unaudited Standalone Financial Results for the Quarter ended 30th June 2023 Re-appointment of Mr. Girishkumar Shah (DIN: 00469291) as WTD & Chairman Re-appointment of Mr. Sanjay Marathe (DIN: 01316388) as MD Appointment of Mrs. Sidhdhi Shah as Additional Director (DIN:00469138) Resignation of Mrs. Neela Marathe (DIN: 00469204) Appointment of M/s. Naresh & Co. as Statutory Auditors of the Company for 5 years subject to shareholders approval at the ensuing AGM. (As Per BSE Announcement dated on 04.08.2023)
13-May-2023 20-May-2023 Accounts Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2023 inter alia to consider and approve 1. Audited Standalone Financial Statements and Results for the 4th quarter and year ended 31st March 2023 for the FY 2022-23. 2. Recommendation of Final Dividend if any for the F.Y. 2022-23 subject to approval of the same by the members in the ensuing Annual General Meeting. Board of Directors of the Company at their meeting held today (i.e., Saturday, 20th May 2023) at the Registered Office of the Company at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia: 1. Considered and approved the Audited Standalone Financial Statements & Results for the Quarter and Year Ended on 31st March 2023 as reviewed and recommended by the Audit Committee along with Audit Report issued by Statutory Auditors of the Company, R. J. Shah & Associates, Chartered Accountants. 2. Recommended Final Dividend for F.Y. 2022-23 at the rate of 20% (Rs. 2/- per share) on the Equity share of Rs. 10/- each subject to the approval of shareholders in the ensuing Annual General Meeting. Board of Directors in its meeting held on 20th May 2023 inter alia, considered and approved the Audited Standalone Financial Statements & Results for the quarter and year ended 31st March 2023 as recommended by the Audit Committee. The Board also recommended Final Dividend for FY 2022-23 at the rate of 20 % (Rs. 2/- per share) on the Equity share of Rs. 10/- each subject to the approval of shareholders in the ensuing Annual General Meeting. We enclose the following: 1. Statement showing the Audited Standalone Financial Results for the quarter and year ended 31st March 2023. 2. Audited Standalone Statement of Assets and Liabilities as on 31st March 2023. 3. Statement of Cash Flow for the year ended 31st March 2023. 4. Auditor's Report issued by the Statutory Auditors of the Company, M/s R. J. Shah & Associates, Chartered Accountants. 5. Declaration as to unmodified opinion of Auditor on the Audited Financial Statements & Results. (As Per BSE Announcement Dated on 20.05.2023) The Board of Directors have recommended Final Dividend for F.Y. 2022-23 at the rate of 20% (Rs. 2/- per share) on the Equity share of Rs. 10/- each subject to the approval of shareholders in the ensuing Annual General Meeting. (As per BSE Announcement Dated on 22/05/2023)
06-Feb-2023 13-Feb-2023 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Unaudited Standalone Financial Results for the 3rd quarter and nine months ended on 31st December 2022 for the FY 2022-23 and other related matters thereto. The Board of Directors of the Company at their meeting held today i.e., 13th February 2023 at the Registered Office of the Company located at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia: Considered and approved the Unaudited Standalone Financial Results for the 3rd quarter and nine months ended 31st December 2022 of the FY 2022-23 as reviewed and recommended by the Audit Committee along with Limited Review Report issued by Statutory Auditors of the Company, R. J. Shah & Associates, Chartered Accountants. Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we enclose the Unaudited Standalone Financial Results for the quarter and nine months ended 31st December 2022. (As Per BSE Announcement Dated on 13/02/2023)
05-Nov-2022 12-Nov-2022 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve Unaudited Standalone Financial Results for the 2nd quarter and half year ended on 30th September 2022 for the FY 2022-23 and other related matters thereto. The Board of Directors of the Company at their meeting held today i.e., Saturday, 12th November 2022 at the Registered Office of the Company located at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia: Considered and approved the Unaudited Standalone Financial Results for the 2nd quarter and Half Year ended 30th September 2022 of the FY 2022-23 as reviewed and recommended by the Audit Committee along with Limited Review Report issued by Statutory Auditors of the Company, R. J. Shah & Associates, Chartered Accountants. (As Per BSE Announcement Dated 12.11.2022)
06-Aug-2022 12-Aug-2022 Quarterly Results Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve Unaudited Standalone Financial Results for the 1st quarter ended on 30th June 2022 for the FY 2022-23 and other related matters thereto. Board of Directors of the Company at their meeting held on Friday, 12th August 2022 at the Registered Office of the Company at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia: 1. Considered and approved the Unaudited Standalone Financial Results for the 1st quarter ended on 30th June 2022 of the FY 2022-23 along with Limited Review Report thereon as reviewed and recommended by the Audit Committee. 2. The Board appointed Kashyap Shah & Co. as Secretarial Auditor for conducting Secretarial Audit of the Company for the Financial Year 2022-23 and issue of certificates. Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we enclose the Unaudited Standalone Financial Results for the quarter ended 30th June 2022. (As per BSE Announcement Dated on 12/08/2022) Publication of Standalone Unaudited Financial Results for the Quarter ended 30th June 2022 (As Per BSE Announcement Dated on 13/08/2022)
14-May-2022 20-May-2022 Accounts Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2022 inter alia to consider and approve 1. Audited Standalone Financial Statements and Results of the Company for the half year and year ended 31st March 2022. 2. Recommendation of Final Dividend if any for the F.Y. 2021-22 subject to approval of the same by the members in the ensuing Annual General Meeting Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2022 ,inter alia, to consider and approve 1. Audited Standalone Financial Statements and Results of the Company for the half year and year ended 31st March 2022. 2. Recommendation of Final Dividend, if any for the F.Y. 2021-22, subject to approval of the same by the members in the ensuing Annual General Meeting The Board recommended Final Dividend for FY 2021-22 at the rate of 20 % (Rs. 2/- per share) on the Equity share of Rs. 10/- each subject to the approval of shareholders in the ensuing Annual General Meeting Board of Directors of the Company at their meeting held on Friday, 20th May 2022 at the Registered Office of the Company at 330, Trivia Complex, Natubhai Circle, Racecourse, Vadodara- 390007, Gujarat; inter alia, passed the following resolutions/decisions: 1. The Board considered and approved the Audited Standalone Financial Statements & Results for the Half Year and Year Ended on 31st March 2022 as reviewed and recommended by the Audit Committee. 2. The Board recommended Final Dividend for FY 2021-22 at the rate of 20 % (Rs. 2/- per share) on the Equity share of Rs. 10/- each subject to the approval of shareholders in the ensuing Annual General Meeting. Board of Directors in its meeting approved the Audited Standalone Financial Statements & Results for the half year and year ended 31st March 2022. The Board also recommended Final Dividend for FY 2021-22 at the rate of 20 % (Rs. 2.00 /- per share) on the Equity share of Rs. 10/- each subject to the approval of shareholders in the ensuing Annual General Meeting. Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we enclose the following: 1. Statement showing the Audited Standalone Financial Results for the half year and year ended 31st March 2022. 2. Audited Standalone Statement of Assets and Liabilities as on 31st March 2022. 3. Statement of Cash Flow for the year ended 31st March 2022. 4. Auditor's Report issued by the Statutory Auditors of the Company, M/s R. J. Shah & Associates, Chartered Accountants. 5. Declaration as to unmodified opinion of Auditor on the Audited Financial Statements & Results. (As Per BSE Announcement Dated on 20.05.2022)
16-Feb-2022 19-Feb-2022 Postal Ballot Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/02/2022 inter alia to consider and approve Migration of equity shares of the company from SME Platform of BSE Limited to Main Board of BSE Limited subject to approval of the BSE Limited and shareholders of the Company.The Board of Directors of the Company in its meeting held today i.e., 19th February 2022 inter-alia has 1. Considered and approved Migration of equity shares of the Company from SME Platform of BSE Limited to Main Board of BSE Limited subject to approval of the BSE Limited and shareholders of the Company. 2. Approved the postal ballot notice for seeking consent of members of the Company by way of a special resolution for the migration of Equity Shares of the Company from SME Platform of BSE to the Main Board of BSE. 3. Appointment of Scrutinizer to conduct the Postal Ballot process. (As Per BSE Announcement Dated on 19/02/2022)
26-Oct-2021 01-Nov-2021 Half Yearly Results Half Yearly Results In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors of the Company at their meeting held today i.e. 1st November 2021 at the Registered Office of the Company at 330 Trivia Complex Natubhai Circle Racecourse Road Vadodara- 390007 inter alia passed the following resolutions/decisions: 1. The Board considered and approved the Unaudited Standalone Financial Statements together with Statement of Assets and Liabilities and Cash Flow Statement for the Half Year ended on 30th September 2021 as reviewed and recommended by the Audit Committee. 2. The Board appointed Kashyap Shah & Co. as Secretarial Auditor for conducting Secretarial Audit of the Company for the Financial Year 2021-22 and issue of certificates. Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we enclose the following: 1. Statement showing the Unaudited Standalone Financial Results for the half year ended 30th September 2021. 2. Statements of Assets and Liabilities as on 30th September 2021. 3. Cash Flow Statement for the half year ended 30th September 2021. 4. Limited Review Report issued by the Statutory Auditor of the Company. Kindly take above as compliance of Regulation 33 and 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 11/1/2021 2:00:27 AM)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +